Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support

By Gulbrandsen N.   Wisløff F.   Brinch L.   Carlson K.   Dahl I.M.   Gimsing P.   Hippe E.   Hjorth M.   Knudsen L.M.   Lamvik J.   Lenhoff S.   Løfvenberg E.   Nesthus I.   Lanng Nielsen J.   Turesson I.   Westin J.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 65-77

Humana Press, Inc

Access to resources Recommend Favorite

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

By Schuster Michael  

Supportive Care in Cancer, Vol. 16, Iss. 5, 2008-05 ,pp. : 477-483

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support

By Kollmannsberger C.   Schleucher N.   Rick O.   Metzner B.   Hartmann J.T.   Schoffski P.   Beyer J.   Casper J.   Sosada M.   Schmoll H.-J.   Bohlke I.   Meisner C.   Kanz L.   Bokemeyer C.  

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 775-782

Elsevier

Access to resources Recommend Favorite

Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer

By Ikeba Kazunori   Okubo Mitsuo   Takeda Satoru   Kinoshita Katsuyuki   Maeda Hiroo  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 113-119

Springer Publishing Company

Access to resources Recommend Favorite

Hepatitis B Virus Reactivation in Patients Receiving Chemotherapy for Cancer Treatment: Role of Lamivudine Prophylaxis

By Coiffier Bertrand  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 548-552

Informa Healthcare

Access to resources Recommend Favorite